Article Details
Retrieved on: 2024-08-27 14:46:32
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
COSCIENS Biopharma Inc. disclosed top-line results from its Phase 3 DETECT-Trial aimed at diagnosing childhood-onset growth hormone deficiency, ...
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here